[ Price : $8.95]
FDA publishes a draft guidance entitled Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): Establishing Drug Development Progra...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Migraine: Developing Drugs for Preventive Treatment.[ Price : $8.95]
Federal Register notice: FDA withdraws approval of eight ANDAs from multiple applicants after they informed the agency that the pr...[ Price : $8.95]
FDA approves Pfizers Abrysvo vaccine to prevent respiratory syncytial virus in older adults.[ Price : $8.95]
FDA approves AstraZeneca and Mercks Lynparza (olaparib) in combination with Janssens Zytiga (abiraterone) and prednisone or predni...[ Price : $8.95]
FDA publishes a draft guidance on the clinical development of drugs to prevent migraine.[ Price : $8.95]
AstraZeneca says it is ending its brazikumab development program that was being studied for Crohns disease and ulcerative colitis....[ Price : $8.95]
FDA issues a warning against using unapproved products that claim to treat molluscum.